Last Update 02 Jun 26
Fair value Increased 4.99%G: Full Valuations And Dividend Strength Will Guide Balanced Future Returns
The analyst fair value estimate for Assicurazioni Generali has moved from about €36.93 to €38.77, with analysts pointing to mixed but generally stabilizing views on valuation and earnings quality behind recent price target adjustments around €38 to €40.
Analyst Commentary
Recent Street research around Assicurazioni Generali reflects a more balanced stance, with price targets clustering around €38 to €40 and ratings centering on neutral or hold views. The focus for many analysts is how current pricing lines up with fundamentals and whether recent execution can justify these target ranges.
Bullish Takeaways
- Bullish analysts see support for current valuation levels around €38 to €40, suggesting the stock is broadly in line with their assessment of fair value rather than looking materially stretched.
- The move to more neutral ratings from previously more cautious views signals to some that key execution risks may be better reflected in the current share price.
- Incremental price target increases, such as the move to €38, indicate that some analysts are slightly more comfortable with earnings quality and the company’s ability to deliver on current expectations.
- The relatively tight band of targets around the current fair value estimate points to a degree of confidence that recent performance metrics support today’s valuation framework.
Bearish Takeaways
- Bearish analysts argue that valuations in the European insurance group are “looking fuller,” which for them limits upside potential from current levels.
- Neutral and hold ratings suggest that, in their view, the risk or reward trade off is not especially compelling at recent prices, with investors potentially being paid more for stability than for growth.
- Where price targets are held flat around €38.50, analysts are signaling that they do not yet see a clear catalyst that would justify moving to a more positive stance.
- The emphasis on fuller valuations reinforces the idea that any execution slip or earnings disappointment could pressure the stock more than it might if it were trading at a clearer discount.
What's in the News
- Assicurazioni Generali reported gross written premiums of €28.2b, with a 6.8% rise supported by inflows in both Life and Property & Casualty segments, according to recent company results.
- The operating result was €2.2b with an 8.1% increase, and the adjusted net result was €1.3b with a 5.2% rise, with management pointing to improved margins across the business, based on company disclosures.
- The Solvency II ratio stood at 212%, and the company reaffirmed guidance for the Life new business margin to remain at or above 5.5% through 2026, highlighting management's stated confidence in its plan, per recent results.
- Assicurazioni Generali announced an annual dividend of €1.64 per share, with ex date on May 18, 2026, record date on May 19, 2026, and payment on May 20, 2026, according to company dividend information.
- The company has scheduled an Analyst and Investor Day, providing another touchpoint for updated guidance and capital allocation commentary, based on corporate event disclosures.
Valuation Changes
- Fair Value increased from €36.93 to €38.77, indicating a modest uplift in the analyst fair value estimate for the stock.
- The Discount Rate moved from 8.92% to 8.94%, suggesting limited change in the assumed risk profile used in the valuation work.
- Revenue Growth decreased from 25.55% to 25.03%, pointing to a slightly more cautious stance on future € revenue expansion assumptions.
- Net Profit Margin rose from 4.63% to 4.71%, reflecting a small improvement in expected profitability on each € of revenue.
- Future P/E increased from 13.14x to 13.74x, indicating a modestly higher earnings multiple being used in the updated valuation.
Key Takeaways
- Digital transformation and AI integration are enhancing efficiency, pricing, and underwriting, driving operational improvements and stable margins.
- Diversification into high-growth markets and sustainability initiatives are strengthening revenue streams and improving stability and reputation.
- Heavy reliance on government bonds, underperformance in key segments, and rising capital requirements threaten margins, growth prospects, capital efficiency, and shareholder returns.
Catalysts
About Assicurazioni Generali- Provides various insurance solutions under the Generali brand in the Americas, Italy, rest of Europe, Africa, the Middle East, Asia, and the Oceania.
- Continued premium growth and margin expansion in the Life and Protection, Health & Accident segments, supported by demographic shifts like an aging population in Europe, position Generali for sustained revenue and earnings growth as long-term demand for retirement and health solutions increases.
- Strategic investments in digitalization and artificial intelligence are enhancing distribution efficiency, pricing sophistication, and underwriting capabilities, setting Generali up for future improvements in operational efficiency, lower expense ratios, and resilient net margins.
- Expansion and strong growth in Central Eastern Europe and select Asian markets are diversifying the revenue base towards higher-growth geographies, creating multi-year tailwinds for top-line and earnings growth and mitigating sluggishness in mature Western European markets.
- Ongoing focus on growing the capital-light and fee-based asset management segment, as evidenced by strong inflows and improved margins, is expected to increase net profit stability and boost return on equity over the medium to long term.
- Emphasis on sustainability in operations and investment-alongside leadership in protection products and ESG integration-should improve Generali's reputation among institutional investors, facilitate access to lower-cost capital, and help safeguard long-term profitability.
Assicurazioni Generali Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Assicurazioni Generali's revenue will grow by 25.0% annually over the next 3 years.
- Analysts assume that profit margins will shrink from 7.2% today to 4.7% in 3 years time.
- Analysts expect earnings to reach €5.3 billion (and earnings per share of €3.66) by about June 2029, up from €4.2 billion today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as €4.2 billion.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 13.7x on those 2029 earnings, down from 13.8x today. This future PE is lower than the current PE for the GB Insurance industry at 14.0x.
- Analysts expect the number of shares outstanding to decline by 0.98% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 8.94%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Persistently low reinvestment yields and the company's reliance on government bonds-especially the noted increase in Italian government debt exposure-could constrain investment income and compress net margins over time if interest rates remain volatile or suppressed.
- The direct insurance channel in Italy is currently running at an undiscounted combined ratio of 105% and is less profitable than in the past, which, if not effectively turned around, may weigh on overall earnings and reduce the projected positive impact from digitalization.
- Expansion outside of Europe, particularly in Asia, is triggering higher Solvency II capital requirements due to regulatory non-equivalence, potentially depressing Solvency ratios and restricting capital efficiency, which could impair long-term earnings and hinder growth targets.
- Industry pricing cycles-especially in non-motor, health, and global corporate/commercial lines-are described as entering softer phases in certain regions, which, if not counteracted by sufficient risk premium spreads, could pressure revenue growth and operating margins.
- Cash remittances and capital release from certain markets such as Switzerland remain subdued until at least 2026–2027, constraining immediate cash flow and possibly affecting dividend/distribution policies or reinvestment capacity, thus limiting short
- to medium-term growth in shareholder returns.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of €38.77 for Assicurazioni Generali based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €46.01, and the most bearish reporting a price target of just €28.5.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €113.0 billion, earnings will come to €5.3 billion, and it would be trading on a PE ratio of 13.7x, assuming you use a discount rate of 8.9%.
- Given the current share price of €38.4, the analyst price target of €38.77 is 1.0% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Assicurazioni Generali?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.